Home › Multiple Myeloma › California › Santa Monica
Pag-aaral pangklinika para sa Multiple Myeloma sa Santa Monica, CA
Isang pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Santa Monica. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Nagre-recruitPhase 2
- Beverly Hills Cancer Center (BHCC), Beverly Hills · 6 mi ang layo
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Nagre-recruitPhase 3
- Research Site, Santa Monica
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 3
- Beverly Hills Cancer Center Clinical Research Advisors LLC, Beverly Hills · 6 mi ang layo
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Nagre-recruitPhase 3
- Beverly Hills Cancer Center, Beverly Hills · 6 mi ang layo
- Clinical Research Advisors (Encino Satellite Location), Encino · 10 mi ang layo
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Nagre-recruitPhase 3
- Research Site, Santa Monica
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Nagre-recruitPhase 1
- UCLA Health, Jonsson Comprehensive Cancer Center, Santa Monica
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 1
- Beverly Hills Cancer Center /ID# 266921, Beverly Hills · 6 mi ang layo
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Nagre-recruitPhase 3
- GSK Investigational Site, Beverly Hills · 6 mi ang layo
Pag-aaral para sa Multiple Myeloma sa ibang lungsod
- New York City, NY60 pag-aaral
- Boston, MA42 pag-aaral
- Atlanta, GA42 pag-aaral
- Houston, TX38 pag-aaral
- Durham, NC37 pag-aaral
- Nashville, TN32 pag-aaral
- Denver, CO27 pag-aaral
- St. Louis, MO24 pag-aaral
- Rochester, MN24 pag-aaral
- Columbus, OH24 pag-aaral
- Baldwin Park, CA23 pag-aaral
- Edison, NJ22 pag-aaral
Iba pang pag-aaral sa Santa Monica
- Non-Small Cell Lung Cancer45 pag-aaral
- Kanser sa Suso28 pag-aaral
- Colorectal Cancer23 pag-aaral
- Kanser (lahat ng uri)22 pag-aaral
- Metastatic Cancer19 pag-aaral
- Kanser sa Baga15 pag-aaral
- Kanser sa Ovary15 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg13 pag-aaral
- Pagkabigo ng Puso11 pag-aaral
- Kanser ng Endometrium10 pag-aaral
- Kanser sa Tiyan9 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.